J Allergy Clin Immunol Pract. Special Article: Risk Communication During COVID-19

[tetano]

J Allergy Clin Immunol Pract. 2020 Apr 15. pii: S2213-2198(20)30363-9. doi: 10.1016/j.jaip.2020.04.012. [Epub ahead of print]
Special Article: Risk Communication During COVID-19.


Abrams EM¹, Greenhawt M².

Author information




Abstract

During the unprecedented times caused by the novel coronavirus COVID-19, there is rapidly evolving information and guidance. However, a focus must also be on proper and effective risk communication. This is especially the case during pandemics that have high rates of infection, significant morbidity, lack of therapeutic measures, and rapid increases in cases, all of which apply to the current COVID-19 pandemic. A consequence of poor risk communication and heightened risk perception is hoarding behavior, which can lead to lack of medications and personal protective equipment. One potential way to ensure appropriate risk communication is utilizing social media channels, and ensuring an ongoing consistent media presence. Another important step is to include all stakeholders including members of the allergy community in broader public health messaging. As we continue to face unprecedented times in the allergy community, an understanding and appreciation of risk communication will be essential as we communicate with, and inform, our patients, and our colleagues, moving forward.
Copyright ? 2020. Published by Elsevier Inc.



KEYWORDS:

COVID-19; SARS-CoV-2; health policy; pandemic planning; risk communication


PMID:32304834DOI:10.1016/j.jaip.2020.04.012